BioStem Technologies (OTCMKTS:BSEM - Get Free Report) released its quarterly earnings results on Monday. The company reported $0.68 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.31, Zacks reports. The business had revenue of $10.29 million for the quarter, compared to the consensus estimate of $86.69 million.
BioStem Technologies Stock Down 3.8 %
Shares of OTCMKTS:BSEM traded down $0.48 during trading on Friday, reaching $12.25. 96,304 shares of the company traded hands, compared to its average volume of 66,340. The firm has a market capitalization of $204.61 million, a PE ratio of 18.01 and a beta of 0.09. BioStem Technologies has a 52 week low of $6.77 and a 52 week high of $28.26. The company's 50 day moving average is $11.31 and its two-hundred day moving average is $13.74.
About BioStem Technologies
(
Get Free Report)
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Recommended Stories
Before you consider BioStem Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.
While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
